Jeanette Girard, DO, Receives CDI & Department of Internal Medicine's Quality Improvement Award

CDI partners with the Department of Internal Medicine on a new Faculty Quality Improvement Award focused on diabetes.

The Caswell Diabetes Institute is pleased to partner with Michigan Medicine’s Department of Internal Medicine to fund the first diabetes-focused Quality Improvement Pilot Award, an important step in supporting innovative projects that improve care for people living with diabetes and related metabolic conditions.

We are delighted to congratulate Dr. Jeanette Girard on being selected as the 2026 recipient of the Caswell Diabetes Institute and Department of Medicine’s Faculty Quality Improvement Award. Her project, “Improving Screening for Metabolic Associated Steatotic Liver Disease in Patients with Type 2 Diabetes in MEND,” was chosen by the review committee from a highly competitive pool of outstanding submissions.

Dr. Girard’s work reflects the kind of patient-centered, systems-focused improvement that this new award is designed to encourage. By advancing screening for metabolic-associated steatotic liver disease among patients with type 2 diabetes, her project has the potential to strengthen clinical care and improve outcomes for a population at significant risk.

Please join us in congratulating Dr. Girard on this well-deserved recognition and in celebrating this exciting new partnership between the CDI and the Department of Internal Medicine

CDI plans to offer this award annually and expand eligibility next year beyond the Department of Internal Medicine, broadening support for diabetes-focused quality improvement initiatives across Michigan Medicine. Additional information about the award and future funding opportunities is available on the Caswell Diabetes Institute funding opportunities page.

Featured News & Stories

Dr. Njira Lugogo
Department News

Dr. Njira Lugogo Named Healthcare Hero by Crain's Detroit Business

Dr. Njira Lugogo, clinical professor of pulmonary and critical care medicine, was named one of Crain Detroit Business's 2026 Healthcare Heroes.
woman itching skin orange blue button down
Health Lab

A first-of-its-kind treatment for mastocytosis

A new drug called Avapritinib achieved longterm safety approval for indolent systemic mastocytosis.
Hello and welcome message
Department News

Biological Chemistry welcomes new MS and PhD students

New graduate students join the Department of Biological Chemistry at U-M Medical School.
kid at table not wanting to eat breakfast with parent blurred in background white coloring milk on table
Health Lab

Many parents face challenges getting kids to eat a healthy breakfast before school

Three-quarters of parents report at least one barrier to their child starting the day with a healthy meal on a typical school day, according to the University of Michigan Health C.S. Mott Children’s Hospital National Poll on Children’s Health.
Bill and Sally Martin stand affectionately with their arms around each other. They appear to be in a high open tower above a city.
Philanthropy News

A Gift to Benefit All: Bill and Sally Martin’s Visionary Support for Sports Medicine

With strong ties to U-M athletics, Bill and Sally Martin have made a gift to kickstart fundraising for the Nathan and Catherine Forbes Sports Medicine Institute at the University of Michigan.
Microscope images of prostate cancer cells
Health Lab

New drug combination may help treat advanced prostate cancer

University of Michigan researchers found that combining BET bromodomain and DNMT inhibitors may slow the growth of treatment-resistant prostate cancer by targeting transdifferentiated tumors.